P339: DEVELOPMENT OF ANTI-IL-7RΑ ANTIBODIES AS A TARGETED THERAPY FOR T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

Bibliographic Details
Main Authors: Mafalda Duque, João Santos, Sílvia Andrade, Daniela Teixeira, Maria Pajuelo, Rita Fragoso, João T. Barata
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000968268.99374.53
_version_ 1797280778138157056
author Mafalda Duque
João Santos
Sílvia Andrade
Daniela Teixeira
Maria Pajuelo
Rita Fragoso
João T. Barata
author_facet Mafalda Duque
João Santos
Sílvia Andrade
Daniela Teixeira
Maria Pajuelo
Rita Fragoso
João T. Barata
author_sort Mafalda Duque
collection DOAJ
first_indexed 2024-03-07T16:45:28Z
format Article
id doaj.art-42c956ecfcfe47ee8c5c5cf61a97761c
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T16:45:28Z
publishDate 2023-08-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-42c956ecfcfe47ee8c5c5cf61a97761c2024-03-03T06:27:27ZengWileyHemaSphere2572-92412023-08-017e993745310.1097/01.HS9.0000968268.99374.53202308003-00241P339: DEVELOPMENT OF ANTI-IL-7RΑ ANTIBODIES AS A TARGETED THERAPY FOR T-CELL ACUTE LYMPHOBLASTIC LEUKEMIAMafalda Duque0João Santos1Sílvia Andrade2Daniela Teixeira3Maria Pajuelo4Rita Fragoso5João T. Barata61 Instituto de Medicina Molecular João Lobo Antunes; Faculdade de Medicina da Universidade de Lisboa, JBarata Lab, Lisbon, Portugal2 FairJourney Biologics, Porto, Portugal2 FairJourney Biologics, Porto, Portugal2 FairJourney Biologics, Porto, Portugal2 FairJourney Biologics, Porto, Portugal3 Instituto de Medicina Molecular João Lobo Antunes, JBarata Lab, Lisbon, Portugal1 Instituto de Medicina Molecular João Lobo Antunes; Faculdade de Medicina da Universidade de Lisboa, JBarata Lab, Lisbon, Portugalhttp://journals.lww.com/10.1097/01.HS9.0000968268.99374.53
spellingShingle Mafalda Duque
João Santos
Sílvia Andrade
Daniela Teixeira
Maria Pajuelo
Rita Fragoso
João T. Barata
P339: DEVELOPMENT OF ANTI-IL-7RΑ ANTIBODIES AS A TARGETED THERAPY FOR T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
HemaSphere
title P339: DEVELOPMENT OF ANTI-IL-7RΑ ANTIBODIES AS A TARGETED THERAPY FOR T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
title_full P339: DEVELOPMENT OF ANTI-IL-7RΑ ANTIBODIES AS A TARGETED THERAPY FOR T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
title_fullStr P339: DEVELOPMENT OF ANTI-IL-7RΑ ANTIBODIES AS A TARGETED THERAPY FOR T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
title_full_unstemmed P339: DEVELOPMENT OF ANTI-IL-7RΑ ANTIBODIES AS A TARGETED THERAPY FOR T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
title_short P339: DEVELOPMENT OF ANTI-IL-7RΑ ANTIBODIES AS A TARGETED THERAPY FOR T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
title_sort p339 development of anti il 7rα antibodies as a targeted therapy for t cell acute lymphoblastic leukemia
url http://journals.lww.com/10.1097/01.HS9.0000968268.99374.53
work_keys_str_mv AT mafaldaduque p339developmentofantiil7raantibodiesasatargetedtherapyfortcellacutelymphoblasticleukemia
AT joaosantos p339developmentofantiil7raantibodiesasatargetedtherapyfortcellacutelymphoblasticleukemia
AT silviaandrade p339developmentofantiil7raantibodiesasatargetedtherapyfortcellacutelymphoblasticleukemia
AT danielateixeira p339developmentofantiil7raantibodiesasatargetedtherapyfortcellacutelymphoblasticleukemia
AT mariapajuelo p339developmentofantiil7raantibodiesasatargetedtherapyfortcellacutelymphoblasticleukemia
AT ritafragoso p339developmentofantiil7raantibodiesasatargetedtherapyfortcellacutelymphoblasticleukemia
AT joaotbarata p339developmentofantiil7raantibodiesasatargetedtherapyfortcellacutelymphoblasticleukemia